Video: Four integrated technologies for biologics developability assessment

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics.

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development. The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability and aggregation, which enables better pipeline decisions.